-
Something wrong with this record ?
Preparatory production of quercetin-3-β-D-glucopyranoside using alkali-tolerant thermostable α-L-rhamnosidase from Aspergillus terreus
L. Weignerová, P. Marhol, D. Gerstorferová, V. Křen
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Alkalies pharmacology MeSH
- Aspergillus drug effects enzymology MeSH
- beta-Glucosidase metabolism MeSH
- Bioreactors microbiology MeSH
- Biotechnology methods MeSH
- Biotransformation drug effects MeSH
- Adaptation, Physiological drug effects MeSH
- Glucosides biosynthesis chemistry MeSH
- Glycoside Hydrolases metabolism MeSH
- Hydrogen-Ion Concentration drug effects MeSH
- Quercetin analogs & derivatives biosynthesis chemistry MeSH
- Rutin chemistry metabolism MeSH
- Enzyme Stability drug effects MeSH
- Temperature MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Extensive screening for a robust producer of α-L-rhamnosidase activity from well-defined strains of filamentous fungi, including multifactorial optimization (inducers, cultivation conditions) was accomplished. Enzyme production of the optimal producer Aspergillus terreus (non-toxigenic) was scaled up to 50L. α-L-Rhamnosidase, which was fully characterized, proved to be thermo- and alkali-tolerant, thus enabling effective operation at 70°C and pH 8.0. These conditions allow for a very high substrate (rutin) load up to 100-300 g/L, thus enabling very high volumetric productivity of the reaction product quercetin-3-β-D-glucopyranoside (isoquercitrin). Here, a novel concept of "immobilised substrate" is used. Isoquercitrin is a highly effective and biocompatible antioxidant with strong anti-inflammatory activities. Rutin biotransformation was optimized and scaled up to ca 10 kg production and thus the robustness of the large-scale production was demonstrated. Isoquercitrin can be produced to a very high purity (98%) in multikilogram amounts, without any quercetin and directly applicable in nutraceuticals.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034909
- 003
- CZ-PrNML
- 005
- 20160729151818.0
- 007
- ta
- 008
- 121023s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biortech.2011.08.029 $2 doi
- 035 __
- $a (PubMed)21890350
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Weignerová, Lenka $7 xx0104801 $u Institute of Microbiology, Center for Biocatalysis and Biotransformation, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 245 10
- $a Preparatory production of quercetin-3-β-D-glucopyranoside using alkali-tolerant thermostable α-L-rhamnosidase from Aspergillus terreus / $c L. Weignerová, P. Marhol, D. Gerstorferová, V. Křen
- 520 9_
- $a Extensive screening for a robust producer of α-L-rhamnosidase activity from well-defined strains of filamentous fungi, including multifactorial optimization (inducers, cultivation conditions) was accomplished. Enzyme production of the optimal producer Aspergillus terreus (non-toxigenic) was scaled up to 50L. α-L-Rhamnosidase, which was fully characterized, proved to be thermo- and alkali-tolerant, thus enabling effective operation at 70°C and pH 8.0. These conditions allow for a very high substrate (rutin) load up to 100-300 g/L, thus enabling very high volumetric productivity of the reaction product quercetin-3-β-D-glucopyranoside (isoquercitrin). Here, a novel concept of "immobilised substrate" is used. Isoquercitrin is a highly effective and biocompatible antioxidant with strong anti-inflammatory activities. Rutin biotransformation was optimized and scaled up to ca 10 kg production and thus the robustness of the large-scale production was demonstrated. Isoquercitrin can be produced to a very high purity (98%) in multikilogram amounts, without any quercetin and directly applicable in nutraceuticals.
- 650 _2
- $a fyziologická adaptace $x účinky léků $7 D000222
- 650 _2
- $a alkálie $x farmakologie $7 D000468
- 650 _2
- $a Aspergillus $x účinky léků $x enzymologie $7 D001230
- 650 _2
- $a bioreaktory $x mikrobiologie $7 D019149
- 650 _2
- $a biotechnologie $x metody $7 D001709
- 650 _2
- $a biotransformace $x účinky léků $7 D001711
- 650 _2
- $a stabilita enzymů $x účinky léků $7 D004795
- 650 _2
- $a glukosidy $x biosyntéza $x chemie $7 D005960
- 650 _2
- $a glykosidhydrolasy $x metabolismus $7 D006026
- 650 _2
- $a koncentrace vodíkových iontů $x účinky léků $7 D006863
- 650 _2
- $a quercetin $x analogy a deriváty $x biosyntéza $x chemie $7 D011794
- 650 _2
- $a rutin $x chemie $x metabolismus $7 D012431
- 650 _2
- $a teplota $7 D013696
- 650 _2
- $a beta-glukosidasa $x metabolismus $7 D001617
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Marhol, Petr $7 xx0161620 $u Institute of Microbiology, Center for Biocatalysis and Biotransformation, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ 142 20, Prague 4, Czech Republic
- 700 1_
- $a Gerstorferová, Daniela $7 _AN061305 $u Institute of Microbiology, Center for Biocatalysis and Biotransformation, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ 142 20, Prague 4, Czech Republic; Department of Biochemistry and Microbiology, Institute of Chemical Technology, Chemická 5, CZ 160 00, Prague 6, Czech Republic
- 700 1_
- $a Křen, Vladimír $7 xx0070803 $u Institute of Microbiology, Center for Biocatalysis and Biotransformation, Academy of Sciences of the Czech Republic, Vídeňská 1083, CZ 142 20, Prague 4, Czech Republic
- 773 0_
- $w MED00000780 $t Bioresource technology $x 1873-2976 $g Roč. 115(2012), s. 222-227
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21890350 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20160729151620 $b ABA008
- 999 __
- $a ok $b bmc $g 956919 $s 792406
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 115 $d 222-227 $i 1873-2976 $m Bioresource technology $n Bioresour Technol $x MED00000780
- LZP __
- $b NLK112 $a Pubmed-20121023